Altres autors/es

Institut Català de la Salut

[Putot A] Médecine Interne et Maladies Infectieuses, Hôpitaux du Pays du Mont-blanc, Sallanches, France. [Garin N] Department of Internal Medicine, Riviera-Chablais Hospitals, Switzerland. Department of Medicine, Geneva University Hospitals, Switzerland. [Rello J] IMAGINE, UR-UM 107, University of Montpellier, Division of Anaesthesia Critical Care, Pain and Emergency Medicine, Nîmes University Hospital, Nîmes, France. Medicine Department, Universitat Internacional de Catalunya, Spain. Grup de Recerca Clínica/Innovació en la Pneumònia i Sèpsia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. [Prendki V] Division of Internal Medicine for the Aged, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland. Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland

Vall d'Hebron Barcelona Hospital Campus

Data de publicació

2025-05-07T07:40:35Z

2025-05-07T07:40:35Z

2025-05



Resum

Diagnosis; Older people; Pneumonia


Diagnòstic; Gent gran; Pneumònia


Diagnóstico; Personas mayores; Neumonía


Pneumonia is a leading cause of death and functional decline in the older population. Diagnosis of pneumonia conventionally includes the presence of respiratory signs and symptoms, systemic signs of infection and a radiographic demonstration of lung involvement. Pneumonia diagnosis in the very old patient is compromised by atypical and unspecific presentation, resulting in a high proportion of false positive diagnosis. Chest radiograph is frequently of low quality and inconclusive in older patients. Computed tomography scan and chest ultrasound may provide valuable diagnostic confirmation in uncertain cases. Bacterial pneumonia has been mainly studied, but viruses, among which influenza, SARS-CoV-2, and respiratory syncytial virus, are increasingly recognized as major players. The decision to treat pneumonia is usually based on a triple assessment of diagnostic probability, disease severity and the general assessment of the patient (frailty, comorbidities, place of living, and goals of care). Antimicrobial treatment is probabilistic, targeting common pathogens. The optimal antibiotic treatment depends on epidemiological data, setting of acquisition, comorbidities, risk factors for methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, or aspiration pneumonia, and severity. Recent controlled trials have demonstrated the non-inferiority of short regimen in non-severe community acquired pneumonia, even in older individuals and a five-day antibiotic treatment is recommended in case of clinical improvement. Pneumonia management in older patients requires a comprehensive approach, including control of comorbidities (particularly cardiovascular), nutritional support, rehabilitation, and prevention of aspiration. Finally, pneumonia may be a pre-terminal event in many patients, requiring advanced-care planning and prompt instauration of palliative management.

Tipus de document

Article


Versió publicada

Llengua

Anglès

Matèries i paraules clau

Medicaments antibacterians - Ús terapèutic; Pneumònia - Diagnòstic; Pneumònia - Tractament; Malalties bacterianes; Pneumònia - Tomografia; Persones grans; DISEASES::Bacterial Infections and Mycoses::Bacterial Infections::Pneumonia, Bacterial; Other subheadings::Other subheadings::/diagnosis; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Image Interpretation, Computer-Assisted::Tomography, X-Ray Computed; CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents; Other subheadings::Other subheadings::/therapeutic use; NAMED GROUPS::Persons::Age Groups::Adult::Aged; ENFERMEDADES::infecciones bacterianas y micosis::infecciones bacterianas::neumonía bacteriana; Otros calificadores::Otros calificadores::/diagnóstico; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::diagnóstico por imagen::interpretación de imágenes asistida por ordenador::tomografía computarizada por rayos X; COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos; Otros calificadores::Otros calificadores::/uso terapéutico; DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::adulto::anciano

Publicat per

Elsevier

Documents relacionats

European Journal of Internal Medicine;135

https://doi.org/10.1016/j.ejim.2025.02.025

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)